busulfan has been researched along with Multiple Primary Neoplasms in 7 studies
Excerpt | Relevance | Reference |
---|---|---|
"Acute non-lymphocytic leukemia occurred in eight women following long-term treatment with Treosulfan (= dihydroxybusulfan) for ovarian carcinoma." | 7.66 | Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan). ( Ernst, P; Ersbøl, J; Hou-Jensen, K; Knudtzon, S; Larsen, MS; Nissen, NI; Pedersen-Bjergaard, J; Rose, C; Sørensen, HM, 1980) |
"Acute non-lymphocytic leukemia occurred in eight women following long-term treatment with Treosulfan (= dihydroxybusulfan) for ovarian carcinoma." | 3.66 | Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan). ( Ernst, P; Ersbøl, J; Hou-Jensen, K; Knudtzon, S; Larsen, MS; Nissen, NI; Pedersen-Bjergaard, J; Rose, C; Sørensen, HM, 1980) |
"Chlorambucil and melphalan were the most leukemogenic drugs, followed by thiotepa; cyclophosphamide and treosulfan were the weakest leukemogens, and the effect per gram was substantially lower at high doses than at lower doses." | 2.67 | Leukemia following chemotherapy for ovarian cancer. ( Bell, J; Clarke, EA; Day, NE; Høst, H; Kaldor, JM; Karjalainen, S; Mehnert, W; Pedersen, D; Pettersson, F; Prior, P, 1990) |
"A patient with acute myeloblastic leukemia received high-dose busulfan (1 mg/kg by mouth every 6 h for 4 days) as myelo-ablative therapy for autologous bone marrow transplantation." | 1.28 | Cerebrospinal fluid and plasma concentrations of busulfan during high-dose therapy. ( Ehrsson, H; Hassan, M; Oberg, G; Simonsson, B; Smedmyr, B; Tötterman, T; Wallin, I, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (85.71) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pedersen-Bjergaard, J | 1 |
Nissen, NI | 1 |
Sørensen, HM | 1 |
Hou-Jensen, K | 1 |
Larsen, MS | 1 |
Ernst, P | 1 |
Ersbøl, J | 1 |
Knudtzon, S | 1 |
Rose, C | 1 |
Stott, H | 2 |
Fox, W | 2 |
Girling, DJ | 2 |
Stephens, RJ | 2 |
Galton, DA | 1 |
Kaldor, JM | 1 |
Day, NE | 1 |
Pettersson, F | 1 |
Clarke, EA | 1 |
Pedersen, D | 1 |
Mehnert, W | 1 |
Bell, J | 1 |
Høst, H | 1 |
Prior, P | 1 |
Karjalainen, S | 1 |
Papineschi, F | 1 |
Bonini, R | 1 |
Pistolisi, D | 1 |
Spremolla, G | 1 |
Hassan, M | 1 |
Ehrsson, H | 1 |
Smedmyr, B | 1 |
Tötterman, T | 1 |
Wallin, I | 1 |
Oberg, G | 1 |
Simonsson, B | 1 |
Firusian, N | 1 |
Reis, HE | 1 |
Gallmeier, W | 1 |
Schmidt, CG | 1 |
3 trials available for busulfan and Multiple Primary Neoplasms
Article | Year |
---|---|
Acute leukaemia after busulphan.
Topics: Acute Disease; Bronchial Neoplasms; Busulfan; Cyclophosphamide; Dose-Response Relationship, Drug; Hu | 1977 |
Leukemia following chemotherapy for ovarian cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Case-Control Studie | 1990 |
Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma.
Topics: Aged; Busulfan; Carcinoma, Bronchogenic; Clinical Trials as Topic; Combined Modality Therapy; Cyclop | 1985 |
4 other studies available for busulfan and Multiple Primary Neoplasms
Article | Year |
---|---|
Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan).
Topics: Adult; Aged; Busulfan; Chromosome Aberrations; Female; Humans; Leukemia; Middle Aged; Neoplasms, Mul | 1980 |
[Chronic myeloid leukemia and carcinoma of the prostate].
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Busulfan; Cyproterone; Cyproterone Acetate; Humans; Leuk | 1989 |
Cerebrospinal fluid and plasma concentrations of busulfan during high-dose therapy.
Topics: Bone Marrow Transplantation; Busulfan; Half-Life; Humans; Leukemia, Myeloid, Acute; Male; Middle Age | 1989 |
[Syntropy of malignant diseases with hemoblastosis].
Topics: Adenocarcinoma; Aged; Busulfan; Estradiol; Female; Humans; Immunosuppressive Agents; Kidney Neoplasm | 1970 |